News and Announcements
SUDA Letter to Shareholders September 2016
- Published September 16, 2016 5:45PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
13th September 2016, ASX Announcement
SUDA Ltd (ASX:SUD), a leader in oro-mucosal drug delivery, today published its sixth shareholder newsletter, which will be mailed to shareholders.
Mr Stephen Carter, Chief Executive Officer of SUDA said: “The newsletter is a valuable forum for us to put recent news in context; to highlight upcoming events; and to set out in more detail the progress and activities at SUDA.
“In this newsletter, we provide an update on business development activities as we advance towards our first commercial agreements. We describe the progress with ZolpiMist™, our oral insomnia spray, including the successful re-launch in the US and our plans to manufacture and register this unique product in Australia.”
To view the full announcement, please click on the button below.